Dr Reddys Laboratories (RDY) Asset Writedowns and Impairment (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Asset Writedowns and Impairment of $1.0 million for Q2 2023, down 85.71% quarter-over-quarter from $7.0 million in Q4 2022.
Dr Reddys Laboratories (RDY) Asset Writedowns and Impairment (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $1.0 million for Q2 2023.
- In Q2 2023, Asset Writedowns and Impairment changed N/A year-over-year to $1.0 million; the TTM figure through Jun 2023 stood at $8.0 million (changed N/A YoY), while the FY2026 annual figure was $38.0 million, up 90.0% from the prior year.
- Asset Writedowns and Impairment for Q2 2023 stood at $1.0 million, down from $7.0 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $185.0 million in Q3 2019, with the low at $2.0 in Q3 2022.
- The 5-year median for Asset Writedowns and Impairment is $11.0 million (2020), against an average of $55.8 million.
- The sharpest annual moves came in 2020 and 2021: Asset Writedowns and Impairment sank 78.0% in 2020, then changed 0.0% in 2021.
- Dr Reddys Laboratories' Asset Writedowns and Impairment stood at $185.0 million in 2019, then decreased by 2.16% to $181.0 million in 2020, then slumped by 93.92% to $11.0 million in 2021, then sank by 36.36% to $7.0 million in 2022, then sank by 85.71% to $1.0 million in 2023.
- Business Quant data shows RDY's Asset Writedowns and Impairment at $1.0 million in Q2 2023, $7.0 million in Q4 2022, and $2.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 2.00 |
| Sep 30, 2022 | 2.00 |
| Jun 30, 2021 | 11.00 Mn |
| Jun 30, 2021 | 11.00 Mn |
| Sep 30, 2020 | 181.00 Mn |
| Sep 30, 2020 | 181.00 Mn |
| Jun 30, 2020 | 11.00 Mn |
| Jun 30, 2020 | 11.00 Mn |
| Sep 30, 2019 | 185.00 Mn |
| Sep 30, 2019 | 185.00 Mn |
| Jun 30, 2019 | 50.00 Mn |
| Jun 30, 2019 | 50.00 Mn |
| Sep 30, 2013 | -8.00 Mn |
| Sep 30, 2013 | -8.00 Mn |
| Jun 30, 2013 | 507.00 Mn |
| Jun 30, 2013 | 507.00 Mn |